Search tips
Search criteria 


Logo of springeropenLink to Publisher's site
Journal of Molecular Medicine (Berlin, Germany)
J Mol Med. 2010 November; 88(11): 1169–1180.
Published online 2010 August 27. doi:  10.1007/s00109-010-0658-6
PMCID: PMC2956061

The chemokine receptor CXCR5 is pivotal for ectopic mucosa-associated lymphoid tissue neogenesis in chronic Helicobacter pylori-induced inflammation


Ectopic lymphoid follicles are a key feature of chronic inflammatory autoimmune and infectious diseases, such as rheumatoid arthritis, Sjögren's syndrome, and Helicobacter pylori-induced gastritis. Homeostatic chemokines are considered to be involved in the formation of such tertiary lymphoid tissue. High expression of CXCL13 and its receptor, CXCR5, has been associated with the formation of ectopic lymphoid follicles in chronic infectious diseases. Here, we defined the role of CXCR5 in the development of mucosal tertiary lymphoid tissue and gastric inflammation in a mouse model of chronic H. pylori infection. CXCR5-deficient mice failed to develop organized gastric lymphoid follicles despite similar bacterial colonization density as infected wild-type mice. CXCR5 deficiency altered Th17 responses but not Th1-type cellular immune responses to H. pylori infection. Furthermore, CXCR5-deficient mice exhibited lower H. pylori-specific serum IgG and IgA levels and an overall decrease in chronic gastric immune responses. In conclusion, the development of mucosal tertiary ectopic follicles during chronic H. pylori infection is strongly dependent on the CXCL13/CXCR5 signaling axis, and lack of de novo lymphoid tissue formation attenuates chronic immune responses.

Keywords: Chemokines, Tertiary lymphoid tissue, Chronic gastritis, Helicobacter pylori


Chronic inflammatory diseases caused by autoimmune or pathogen-induced processes are often associated with the neogenesis of tertiary lymphoid tissues in non-lymphoid organs. These organized microstructures resemble conventional secondary lymphoid organs, with high endothelial venules, well-defined B and T cell zones, and specialized populations of differentiated stromal cells. The principal molecules mediating embryonic lymphoid organogenesis, i.e., inflammatory cytokines of the tumor necrosis factor/lymphotoxin (LT) family and homeostatic chemokines, are also responsible for the complex sequence of events leading to de novo lymphoid tissue neogenesis [13]. Chemokine (C-X-C motif) ligand 13 (CXCL13) and its receptor CXCR5 have been linked to B cell recruitment in autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and experimental autoimmune encephalomyelitis, in humans and in animal disease models [48]. We recently provided direct evidence for a role of the homeostatic chemokines CXCL13, CCL19, and CCL21 in the formation of tertiary lymphoid tissues in a murine model of chronic antigen-induced arthritis [9]. Furthermore, ectopic transgenic expression of all three chemokines was sufficient to induce de novo lymphoid neogenesis [1013]. Indirect evidence suggests that the same molecular mechanisms also trigger the formation of tertiary lymphoid tissues during chronic inflammation associated with infectious diseases, i.e., Lyme arthritis [14], hepatitis C-induced liver inflammation [15], Propriobacterium acnes [16], Mycobacterium tuberculosis [17, 18], and Helicobacter pylori infection [19, 20].

Chronic inflammation due to persistent H. pylori infection can give rise to organized tertiary lymphoid tissues in the gastric mucosa, also called mucosa-associated lymphoid tissue (MALT). MALT represents a premalignant condition that can eventually lead to gastric MALT lymphomagenesis in a small subset of chronically infected individuals. CXCL13 and its receptor, CXCR5, are highly expressed in reactive and/or malignant areas of lymphoid organization that develop in H. pylori-infected stomach mucosa of humans [20, 21] or in Helicobacter infection models in mice [22]. It was suggested that the CXCR5/CXCL13 signaling axis might be a key molecular regulator of tertiary lymphoid organ formation during the course of Helicobacter-induced gastritis. However, direct experimental evidence has yet to confirm this hypothesis. Therefore, we infected wild-type (Wt) and CXCR5-deficient (CXCR5−/−) mice with the H. pylori strain Hp76 to investigate whether the effector function of de novo developed gastric lymphoid tissue contributes to the sequence and level of chronic infectious inflammation. CXCR5 deficiency leads to a complete lack of gastric tertiary lymphoid tissue formation and an overall reduction of chronic gastric inflammation. Thus, our results establish that H. pylori-induced formation of tertiary lymphoid tissues is crucially dependent on CXCL13/CXCR5-mediated signaling events.

Materials and methods


CXCR5 knockout mice [23] were backcrossed with C57BL/6 mice for 12 generations. CXCR5−/− and C57BL/6 mice were raised under specific pathogen-free conditions and used at 2–3 months of age. All animal studies were performed according to institutional and state guidelines.

H. pylori infection

The mouse-adapted Hp76 strain of H. pylori [24] is a spontaneous streptomycin-resistant derivative of P49. The strain expresses VacA but is CagA negative [25] and was grown under microaerophilic conditions in brain heart infusion broth (Becton Dickinson) supplemented with 10% fetal calf serum (FCS), sodium bicarbonate 100 mM, streptomycin 400 μg/ml, vancomycin 10 μg/ml, nystatin 10 μg/ml, and trimethoprim 2.5 μg/ml. Mice were intragastrically inoculated with 2.5 × 108 CFU H. pylori/100 μl phosphate buffered solution (PBS) after being fasted for 18 h on three successive occasions within a 6-day period. To confirm chronic infection with H. pylori, half of the stomach was homogenized, and bacterial colonization was determined by a plate-dilution method at indicated time points after infection. The second half of the stomach was processed for histological analysis. For the preparation of H. pylori lysate, bacteria were harvested from agar plates, suspended in PBS, sonicated for 90 s at 4°C, and then centrifuged at 2,500×g. The supernatant was harvested, and protein concentration was determined by Bradford assay.

Preparation of cell suspensions and proliferation assay

Spleen and mesenteric lymph node (mLN) cell suspensions were obtained by disruption of the organ in PBS/2% FCS followed by hypotonic lysis to deplete red blood cells. For in vitro proliferation assays, 1 × 106 splenocytes or cells from the mLN were cultured in 200 μl RPMI/10% FCS/10 U/ml interleukin (IL)-2 in the presence or absence of 100 μg/ml H. pylori lysate in 96-well round-bottom microtiter plates (in octuplicates) at 37°C for 72 h. T cell proliferation was assessed by measuring the amounts of interferon-γ (IFN-γ), IL-17, and IL-22 in culture supernatants by enzyme-linked immunosorbent assay (ELISA).

Enzyme-linked immunosorbent assay (ELISA)

For the assessment of H. pylori-specific serum antibody levels, microtiter plates were coated with 10 μg/ml H. pylori lysate, and bound antibodies were detected with horseradish peroxidase (HRP)-conjugated antisera for IgG or IgA (Southern Biotechnology) in conjunction with 3,3′,5,5′-tetramethylbenzidine (TMB) substrate. Sera were diluted 1:500 for IgA and 1:400 for IgG measurements, and the absorbance at 450 nm represents the relative anti-H. pylori IgG or IgA value. All measurements were performed in duplicates, and the Ig levels from different mice were averaged.

To quantitate serum cytokine levels or cytokine expression in culture supernatants, microtiter plates were coated with rat anti-mouse IFN-γ, rat anti-mouse IL-17, or rat anti-mouse IL-22 (all Biolegend). Bound cytokines were detected with biotinylated rat anti-mouse IFN-γ (Becton Dickinson), biotinylated rat anti-mouse IL-17, or biotinylated rat anti-mouse IL-22 (both Biolegend), followed by HRP-conjugated streptavidin and TMB substrate. Recombinant mouse IFN-γ (Becton Dickinson), IL-17, and IL-22 (Biolegend) served as standards. Serum was prepared from blood obtained by cardiac puncture and stored at −80°C.

Histological evaluation and immunohistology

The following primary antibodies were used: Alexa 488-labeled rat anti-mouse CD3 (Biolegend), purified rat ani-mouse CD138, and biotinylated rat anti-mouse B220 (Becton Dickinson), polyclonal rabbit anti-mouse CD3 and CD31 (Abcam), biotinylated rat anti-mouse F4/80 (Serotec), rat anti-mouse PNAd and rat anti-mouse follicular dendritic cell (FDC)-M1 (Becton Dickinson), rat anti-mouse Ki67 (Dako), biotinylated rat anti-mouse Foxp3 and Pacific Blue-labeled hamster anti-mouse CD11c (eBiosciences), and polyclonal rabbit anti-H. pylori (Dako). For paraffin sections, tissues were fixed in 4% phosphate-buffered formaldehyde, embedded in paraffin, cut into 5-μm cross-sections, deparaffinized, and demasked by heat (citrate buffer, pH 6.0) or trypsinization (F4/80, PNAd). For cryosections, tissues were frozen in Tissue Tek OCT compound (Sakura Finetek), cut longitudinal into 5- to 8-μm sections, fixed for 10 min in −20°C acetone, and rehydrated in 50 mM Tris-buffered saline, pH 7.6. Endogenous peroxidase activity was blocked with 3% H2O2, and a biotin-blocking step (Vector Laboratories) was performed before biotinylated antibodies were applied. Primary antibodies were incubated for 2 h at room temperature, followed by an appropriate secondary antibody or/and a streptavidin conjugate (alkaline phosphatase or HRP). Alkaline phosphatase activity was detected using Fast blue salt (Sigma-Aldrich). HRP activity was detected using the AEC detection system (Dako). All slides were mounted in Mowiol solution (11.7% w/v Mowiol, 29.4% w/v glycerine, 0.12 M Tris, pH 8.5). Images were acquired with a Zeiss Axiophot fluorescence microscope with an Axiocam HRc camera and further processed using AxioVision 4.5 software (Carl Zeiss).

The intraepithelial lymphocytes were quantified in H&E stained sections by counting the small and round lymphocytes within the basal portion of the surface epithelium and the gastric pits per 100 epithelial cells according to a previously published standard method used in routine pathology [26].

Statistical analysis

Results are expressed as arithmetic means ± standard error of the mean (SEM). Values of P < 0.05 were considered statistically significant and determined either by an unpaired, two-tailed Mann–Whitney or an unpaired, two-tailed Student's t test, as indicated.


H. pylori infectious status and inflammation

To assess the role of CXCR5 in the development of H. pylori-induced gastric inflammation and lymphoid tissue neogenesis, Wt and CXCR5−/− mice were infected and monitored with respect to bacterial colonization and gastric inflammation (Fig. 1a–c). Colonization levels and pattern were comparable in Wt and CXCR5−/− mice 5 to 7 months after inoculation with the mouse-adapted H. pylori strain Hp76 (Fig. 1b). In both groups, bacteria were found adherent to the surface of foveolar cells or between epithelial cells of the gastric mucosa (Fig. 1c). H. pylori was not detected in stomachs of uninfected animals (data not shown).

Fig. 1
Comparable Helicobacter pylori gastric colonization in Wt and CXCR5−/− mice. a Schematic representation of the experimental H. pylori infection model. b The degree of H. pylori colonization in the gastric mucosa of Wt (black squares; ...

Histomorphological and immunohistochemical analysis was used to determine presence and phenotype of inflammatory infiltrates located in the submucosal and mucosal gastric tissue. Gastritis was graded according to the updated Sydney System [27]. The scoring system distinguishes between active neutrophil-dominated and chronic inflammation, characterized by the prevalence of macrophages, lymphocytes, and plasma cells. All inflammatory infiltrates were scored from 0 to 3. Wt mice exhibited a strong active and a moderate chronic inflammation 7 months after infection. In contrast, CXCR5−/− mice showed significantly reduced active inflammatory scores and only a minor reduction of the chronic inflammatory score (Table 1).

Table 1
Gastric histology of Helicobacter pylori-infected mice

We observed the formation of one or multiple highly organized tertiary lymphoid tissues in chronically infected Wt mice (Fig. 2a and Table 1). Remarkably, the formation of ectopic lymphoid tissue was strongly abrogated in CXCR5−/− mice (Fig. 2b and Table 1). In only two out of 13 CXCR5−/− mice, loose lymphoid aggregates were visible (Fig. 2b). The majority of CXCR5−/− mice displayed less Ki67 staining, a marker for epithelial proliferation, in comparison to Wt mice, which showed pronounced Helicobacter-induced epithelial proliferation (Fig. 3a). Increase of intraepithelial lymphocytes (>25 IELs/100 epithelial cells) and reactive epithelial changes including epithelial regeneration and/or hyperplasia were also scored. Both parameters were reduced in CXCR5−/− mice compared to Wt animals (Table 1 and Fig. 3b). Taken together, CXCR5−/− mice developed less active and chronic gastric inflammation than Wt controls (Table 1 and Fig. 3b).

Fig. 2
Helicobacter pylori-induced formation of ectopic lymphoid follicles in Wt but not in CXCR5−/− mice. Hematoxylin–eosin stainings of paraffin-embedded gastric mucosal tissue sections of three representative H. pylori-infected Wt ...
Fig. 3
Reduced mucosal proliferation and reactive epithelial changes in Helicobacter pylori-infected CXCR5−/− mice. a Mucosal proliferation is indicated by Ki67-staining in red (indicated by an arrow). A lower (upper panels) and higher magnification ...

Chronic infection with H. pylori causes the development of highly organized ectopic lymphoid structures in Wt but not in CXCR5−/− mice

In Wt mice, tertiary lymphoid tissues developed fully within 5–7 months (Table 1) and displayed highly organized microstructures up to 17 months after infection (Figs. 4a and 5a–f; Table 1). This was strongly abrogated in H. pylori-infected CXCR5−/− mice (Fig. 4b and Table 1). Eleven out of 13 CXCR5−/− mice analyzed showed no tertiary lymphoid tissue development (Table 1). In two cases (CXCR5−/− No. 7 and No. 10, Table 1), an active chronic Helicobacter-induced inflammation was accompanied by loose cellular aggregates located in the submucosal and in the mucosal tissue. However, the cellular aggregates consisted mainly of macrophages and some scattered lymphocytes with an abundance of CD31+ blood vessels adjacent to these structures. No proper segregation into T and B cell zones and subsequently no formation of germinal centers (GCs) were observed in CXCR5−/− mice (Fig. 4b).

Fig. 4
Lack of segregated ectopic follicular tissue formation in CXCR5−/− compared to Wt mice. Paraffin sections with ectopic lymphoid follicles of two representative Wt (a) and sections with loose lymphoid aggregates of two CXCR5−/− ...
Fig. 5
Mucosal tertiary lymphoid tissues in WT mice exhibit lymph node-like structures. Paraffin sections with ectopic lymphoid follicles of representative Wt mice were immunohistochemically stained for the formation of HEVs (PNAd, peripheral lymph node addressin, ...

Ectopic follicular structures, which developed regularly in infected Wt mice (Table 1), displayed discrete T cell and B cell areas characteristic of the compartmentalization exhibited by conventional lymphoid organs. In addition to macrophages scattered throughout the submucosal and mucosal tissue, small clusters of macrophages adjacent to follicular structures were observed. Within and adjacent to these lymphoid aggregates, an abundance of CD31+ blood vessels was detected (Fig. 4a). Detailed analysis of these highly structured lymphoid follicles revealed additional similarities to conventional LNs, i.e., a number of blood vessels expressed peripheral lymph node addressin (PNAd) and therefore were characterized as high endothelial venules (HEVs; Fig. 5a). These specialized HEVs allow lymphocyte extravasation from the blood and represent a specific feature of functional lymphoid organs. CD3+ T cell zones contained CD4+, CD8+ (data not shown) intermingled with CD11c+ DCs, and regulatory Foxp3+ T cells (Fig. 5b, c). Proliferating Ki-67+ cells were detected within the B cell-rich area (Fig. 5d), and in some organized tertiary lymphoid tissues, GC-like structures were additionally defined by staining for CD138+ plasma cells and/or FDCs (FDCs; Fig. 5e, f). Taken together, chronic H. pylori infection triggered the formation of organized tertiary lymphoid tissues with characteristics of conventional secondary lymphoid organs. Most importantly, the development of tertiary lymphoid tissue was strongly suppressed in CXCR5−/− mice.

T cell-mediated immune responses to H. pylori are partially impaired in H. pylori-infected CXCR5−/− mice

The development of a Th1-predominant immune response with production of IFN-γ has been observed in humans and mice following infection with Helicobacter [2830]. In addition, the Th17 cytokine IL-17A has been reported to play an important role in mucosal immune responses to Helicobacter infection [31, 32]. Here, we tested if enhanced IFN-γ, IL-17A, and IL-22 production was detectable in response to chronic infection with H. pylori and if the production of inflammatory mediators is altered by CXCR5 deficiency. Serum IFN-γ levels of chronically infected mice were below the detection limit of our ELISA. Serum levels of IL-17A were generally elevated after Helicobacter infection, but this increase was not significantly altered in CXCR5−/− compared to Wt mice (data not shown). Next, we used single-cell suspensions from spleens and mLNs of infected mice and restimulated them with H. pylori antigen in vitro. Splenocytes and mLN-derived lymphocytes from Wt and CXCR5−/− mice were equally capable of producing IFN-γ in response to H. pylori sonicate 7 months after infection (Fig. 6a). This suggests that both mouse strains are capable of mounting a Th1-type cellular response to H. pylori infection. In addition, splenocytes and mLN-derived cells from infected Wt mice also produced increased IL-17A levels compared to non-infected Wt mice. IL-17A concentrations produced in splenocytes derived from infected CXCR5−/− mice were comparable to Wt cells, whereas IL-17A production in mLN-derived cells from infected CXCR5−/− mice was significantly decreased in response to H. pylori sonicate compared to Wt cells (Fig. 6b). We also found that CXCR5 deficiency altered Helicobacter-induced production of IL-22, another Th17-derived cytokine, in mLN-derived cells (Fig. 6c, left panel). Gastrointestinal immune responses directed against mucosal pathogens are predominantly induced in the mucosal associated lymphoid organs, i.e., Peyer's patches (PPs) and mLNs [33]. Hence, Helicobacter-induced cytokine production was generally more prominent in lymphocytes derived from mesenteric LNs than from the spleen, except for IL-22. Overall, CXCR5 expression seems to influence Th17- but not Th1-type cellular immune responses to H. pylori infection.

Fig. 6
Helicobacter pylori-specific Th17 cell proliferation was reduced, but the Th1 responses were unaltered in CXCR5−/− mice. Seven months after infection, cell suspensions from mesenteric LNs and spleens of Wt (black bars; n = 6–7) ...

H. pylori-specific serum IgA and IgG levels are decreased in CXCR5−/− mice

Next, we examined whether CXCR5 deficiency influenced the production of anti-H. pylori-specific antibodies. Serum samples from Wt and CXCR5−/− mice were taken 4 (data not shown) and 7 months after H. pylori infection, and anti-H. pylori IgG and IgA titers were determined by ELISA. The majority of H. pylori-infected Wt mice mounted a strong anti-H. pylori response in comparison to uninfected controls (Fig. 7a, b). In contrast, Helicobacter-specific IgA and IgG levels were strongly reduced in infected CXCR5−/− mice (Fig. 7a, b) compared to infected Wt mice. Basal serum levels for the same subclasses of immunoglobulin are known to be comparable in both groups [23, 34]. In addition, comparable antigen-specific Ig levels of the various subclasses are observed in DNP-KLH-immunized CXCR5−/− and Wt mice [23]. Thus, we conclude that impaired generation of Helicobacter-specific antibodies is not caused by a general inability of CXCR5−/− mice to mount antigen-specific Ig responses to T cell-dependent antigens.

Fig. 7
Decreased serum levels of anti-Helicobacter pylori-specific IgG and IgA in CXCR5−/− mice. a Six to seven months after infection, blood sera from Wt (black bar; n = 17) and CXCR5−/− mice (gray bar; n = 18) ...


In the present study, we provide direct evidence for a pivotal role of CXCR5 in the formation of tertiary lymphoid tissue during Helicobacter-induced chronic gastritis.

A decade ago, it was demonstrated that the ligand for CXCR5 and CXCL13 is highly expressed in gastric lymphoid follicles and in MALT lymphomas of patients with chronic gastritis induced by H. pylori infection [20]. Additional clinical studies have correlated CXCL13/CXCR5 expression with infection-dependent formation of gastric MALT and MALT lymphomas [21, 35]. In experimental mouse models, i.e., chronic experimental tuberculosis and Helicobacter-induced chronic gastritis, formation of lymphoid structures was observed accompanied by expression of the homeostatic chemokine CXCL13, but also CCL19 and CCL21 [17, 18, 22, 36]. However, a genetic in vivo model that would causally link the CXCL13/CXCR5 signaling axis to the pathology of H. pylori infection has not yet been described. Here, we employ CXCR5−/− mice to study CXCR5-dependent formation of tertiary lymphoid tissues during chronic H. pylori infection. We show that the CXCL13/CXCR5 signaling axis is crucial for the development of tertiary lymphoid tissues during H. pylori-induced gastric inflammation. Five to seven months post-Helicobacter instillation, Wt mice developed a chronic H. pylori infection accompanied by the formation of highly organized and fully functional ectopic lymphoid follicles. Strikingly, CXCR5−/− mice failed to develop organized ectopic lymphoid follicles. This impaired tertiary lymphoid tissue formation may be associated with changes in the severity and maintenance of chronic inflammation.

The majority of infected Wt animals developed an active chronic gastritis with increased intraepithelial lymphocyte infiltration, increased epithelial proliferation, and gastric atrophy. In contrast, CXCR5−/− mice showed a reduced gastric inflammation, decreased epithelial proliferation, and subsequently less reactive epithelial pathomorphological changes. This observation is consistent with our previous work using a model of chronic antigen-induced rheumatoid arthritis showing that CXCR5 deficiency leads to a reduction of acute inflammatory parameters, significantly reduced numbers of tertiary lymphoid follicles, and reduced joint destruction [9]. Thus, we have been able to demonstrate CXCR5-dependent formation of tertiary lymphoid tissue and their association with local aberrant chronic immune responses in two independent inflammatory disease models.

Since B cell homing, the development of PPs and some peripheral LNs, as well as GC formation, is generally impaired in these mice [23], reduced inflammation in CXCR5−/− mice might also be explained by an impaired induction of secondary immune responses. However, comparable bacterial burdens in Wt and CXCR5−/− mice suggest that susceptibility to H. pylori infection was not altered by CXCR5 deficiency and that CXCR5−/− mice are still able of mounting an anti-H. pylori immune response. This conclusion is supported by the capability of both, Wt and CXCR5−/− mice, to develop a Th1-like response towards H. pylori with production of IFN-γ. IFN-γ has been described as a key cytokine for Th1 cell-mediated immune responses in the control of Helicobacter infection [2830, 37]. It induces phagocytosis by neutrophils and microbicidal activity and augments the antigen-presenting activity of macrophages and DCs. Although multiple cell types can produce IFN-γ, its secretion by CD4+ Th1 cells seems to be crucial for bacterial clearance [38]. Consistent with previous studies [29, 30, 37], we found that lymphocytes and splenocytes from H. pylori-infected Wt or CXCR5−/− mice produced the Th1-cytokine IFN-γ when they were restimulated with H. pylori sonicate in vitro. However, IFN-γ can play a dual role in the pathology of Helicobacter infection: IFN-γ- and interferon regulatory factor 1-deficient mice show less gastric inflammation and enhanced colonization with H. pylori, suggesting that while IFN-γ is known to protect against H. pylori infection by limiting bacterial growth, upregulation of IFN-γ can promote chronic gastric inflammation [29, 30, 37]. Here, we showed that the IFN-γ-mediated Th1 response during the chronic phase of infection is not significantly altered by the lack of CXCR5.

More recently, another proinflammatory cytokine, IL-17A, has been proposed to exert an important role in anti-Helicobacter mucosal immune responses as well [39]. In several mouse models, it was shown that the host's ability to kill invading pathogens is partially dependent on the IL-23/IL-17 axis [3941]. In our model, a Th17 response was also elicited. Cells cultured from the mLNs of Wt mice expressed increased IL-17A levels after in vitro restimulation with H. pylori sonicate in comparison to uninfected controls. In contrast, cells from the mLNs of infected CXCR5−/− mice showed almost no increase in IL-17A levels. This suggests that CXCR5 deficiency alters IL-17-producing T cell responses upon H. pylori infection. The effect of IL-17A on Helicobacter-induced immune responses remains unclear. Recent work has shown that deletion of the IL-17 gene inhibited H. pylori-induced gastritis [42]. In contrast, Ab-mediated neutralization of IL-17A [43] or blockage of IL-17RA signaling by employing IL-17RA-deficient mice [44] led to an upregulation of chronic mononuclear inflammation elicited by H. pylori infection. IL-17RA-deficient mice also exhibited elevated mucosal levels of the B cell chemoattractant CXCL13. It was suggested that increased CXCL13 levels cause the accelerated B cell-predominant chronic inflammation in the IL-17RA-deficient mice [44]. In our study, decreased expression of IL-17A in the CXCR5−/− mice was not associated with increased mononuclear infiltration. Because CXCL13/CXCR5-mediated effects are blocked in the CXCR5−/− mice, our findings are not mutually exclusive to the data of Algood et al.

A striking difference between Wt and CXCR5−/− mice was seen in H. pylori-specific serum IgG and IgA Ab responses 4 and 7 months after infection. Wt mice mounted a strong anti-H. pylori IgA and IgG Ab response, whereas the majority of CXCR5−/− mice showed only weak anti-H. pylori IgA and IgG Ab titers. Basal serum levels for the same subclasses of immunoglobulin were comparable for non-infected CXCR5−/− and Wt mice as described earlier [23, 34]. Additionally, CXCR5−/− mice exhibited normal levels of switched Ig isotypes after immunization with DNP-keyhole limpet hemocyanin [23]. More recently, the impact of CXCR5 on antiviral B cell responses was assessed. CXCR5−/− mice produced normal levels of neutralizing IgM and IgG Abs in an acute infection with vesicular stomatitis virus (VSV) and also developed VSV-specific GCs [45]. However, under conditions of limited antigenic doses, humoral antiviral B cell responses were significantly reduced in CXCR5−/− mice due to impaired Ag-specific expansion of B cells in secondary lymphoid organs and impaired recruitment of Ag-specific B and Th cells to GCs [45]. Recently, it has been demonstrated that H. pylori is predominantly phagocytosed by DCs in PPs but not in the gastric lamina propria or gastric epithelium [46, 47]. Subsequently, H. pylori antigen-specific CD4+ T cells are primed in PPs and in mLNs. Since CXCR5−/− mice have severely reduced numbers of PPs, one could envisage that less antigen-loaded DCs are generated which could eventually reach the mLN for the priming of T cells. Under such circumstances, lack of CXCR5 might lead to impaired efficacy of T cell-dependent B cell responses against Helicobacter-infection, resulting in a reduced anti-Helicobacter humoral response. In addition, reduced antigenic priming within the mLNs might also influence IL-17A and IL-22 production in mLN-derived cells of infected CXCR5−/− mice.

In summary, our data indicate that CXCR5 crucially regulates the formation of organized ectopic lymphoid follicles during chronic H. pylori-induced gastritis. Lack of tertiary lymphoid tissue development is additionally accompanied by reduced chronic gastric inflammation. We propose that CXCR5 is a promising therapeutic target in chronic inflammation not only associated with autoimmune diseases but also during chronic infectious diseases.


We are grateful to Kerstin Krüger and Heike Schwede for expert technical assistance. We are indebted to Armin Rehm for helpful suggestions and critical reading of the manuscript. The authors thank Markus M. Heimesaat and Andre Fischer for their help with the housing of Helicobacter-infected mice. This research was supported by the Priority Program SFB 633 of the German Research Foundation (DFG) and partially by the Deutsche Krebshilfe e.V.

Disclosure statement All authors do not have a commercial or other association that might pose a conflict of interest.

Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.


1. Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD, Browning JL, Lipp M, Cyster JG. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 2000;406:309–314. doi: 10.1038/35018581. [PubMed] [Cross Ref]
2. Cyster JG. Lymphoid organ development and cell migration. Immunol Rev. 2003;195:5–14. doi: 10.1034/j.1600-065X.2003.00075.x. [PubMed] [Cross Ref]
3. Muller G, Hopken UE, Lipp M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev. 2003;195:117–135. doi: 10.1034/j.1600-065X.2003.00073.x. [PubMed] [Cross Ref]
4. Manzo A, Paoletti S, Carulli M, Blades MC, Barone F, Yanni G, Fitzgerald O, Bresnihan B, Caporali R, Montecucco C, Uguccioni M, Pitzalis C. Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol. 2005;35:1347–1359. doi: 10.1002/eji.200425830. [PubMed] [Cross Ref]
5. Manzo A, Vitolo B, Humby F, Caporali R, Jarrossay D, Dell'accio F, Ciardelli L, Uguccioni M, Montecucco C, Pitzalis C. Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint. Arthritis Rheum. 2008;58:3377–3387. doi: 10.1002/art.23966. [PubMed] [Cross Ref]
6. Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, Crocker J, Hamburger J, Ainsworth J, Mathews J, Salmon M, Bowman SJ, Buckley CD. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren's syndrome. Arthritis Rheum. 2001;44:2633–2641. doi: 10.1002/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9. [PubMed] [Cross Ref]
7. Salomonsson S, Larsson P, Tengner P, Mellquist E, Hjelmstrom P, Wahren-Herlenius M. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjogren's syndrome. Scand J Immunol. 2002;55:336–342. doi: 10.1046/j.1365-3083.2002.01058.x. [PubMed] [Cross Ref]
8. Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 2004;14:164–174. doi: 10.1111/j.1750-3639.2004.tb00049.x. [PubMed] [Cross Ref]
9. Wengner AM, Hopken UE, Petrow PK, Hartmann S, Schurigt U, Brauer R, Lipp M. CXCR5- and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis. Arthritis Rheum. 2007;56:3271–3283. doi: 10.1002/art.22939. [PubMed] [Cross Ref]
10. Fan L, Reilly CR, Luo Y, Dorf ME, Lo D. Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J Immunol. 2000;164:3955–3959. [PubMed]
11. Luther SA, Lopez T, Bai W, Hanahan D, Cyster JG. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity. 2000;12:471–481. doi: 10.1016/S1074-7613(00)80199-5. [PubMed] [Cross Ref]
12. Marinkovic T, Garin A, Yokota Y, Fu YX, Ruddle NH, Furtado GC, Lira SA. Interaction of mature CD3 + CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J Clin Invest. 2006;116:2622–2632. [PMC free article] [PubMed]
13. Martin AP, Coronel EC, Sano G, Chen SC, Vassileva G, Canasto-Chibuque C, Sedgwick JD, Frenette PS, Lipp M, Furtado GC, Lira SA. A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21. J Immunol. 2004;173:4791–4798. [PubMed]
14. Steere AC, Duray PH, Butcher EC. Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum. 1988;31:487–495. doi: 10.1002/art.1780310405. [PubMed] [Cross Ref]
15. Hillan KJ, Hagler KE, MacSween RN, Ryan AM, Renz ME, Chiu HH, Ferrier RK, Bird GL, Dhillon AP, Ferrell LD, Fong S. Expression of the mucosal vascular addressin, MAdCAM-1, in inflammatory liver disease. Liver. 1999;19:509–518. doi: 10.1111/j.1478-3231.1999.tb00084.x. [PubMed] [Cross Ref]
16. Yoneyama H, Matsuno K, Zhang Y, Murai M, Itakura M, Ishikawa S, Hasegawa G, Naito M, Asakura H, Matsushima K. Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease. J Exp Med. 2001;193:35–49. doi: 10.1084/jem.193.1.35. [PMC free article] [PubMed] [Cross Ref]
17. Kahnert A, Hopken UE, Stein M, Bandermann S, Lipp M, Kaufmann SH. Mycobacterium tuberculosis triggers formation of lymphoid structure in murine lungs. J Infect Dis. 2007;195:46–54. doi: 10.1086/508894. [PubMed] [Cross Ref]
18. Schreiber T, Ehlers S, Aly S, Holscher A, Hartmann S, Lipp M, Lowe JB, Holscher C. Selectin ligand-independent priming and maintenance of T cell immunity during airborne tuberculosis. J Immunol. 2006;176:1131–1140. [PubMed]
19. Dogan A, Du M, Koulis A, Briskin MJ, Isaacson PG. Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. Am J Pathol. 1997;151:1361–1369. [PubMed]
20. Mazzucchelli L, Blaser A, Kappeler A, Scharli P, Laissue JA, Baggiolini M, Uguccioni M. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest. 1999;104:R49–R54. doi: 10.1172/JCI7830. [PMC free article] [PubMed] [Cross Ref]
21. Barone F, Bombardieri M, Rosado MM, Morgan PR, Challacombe SJ, Vita S, Carsetti R, Spencer J, Valesini G, Pitzalis C. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. J Immunol. 2008;180:5130–5140. [PubMed]
22. Shomer NH, Fox JG, Juedes AE, Ruddle NH. Helicobacter-induced chronic active lymphoid aggregates have characteristics of tertiary lymphoid tissue. Infect Immun. 2003;71:3572–3577. doi: 10.1128/IAI.71.6.3572-3577.2003. [PMC free article] [PubMed] [Cross Ref]
23. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell. 1996;87:1037–1047. doi: 10.1016/S0092-8674(00)81798-5. [PubMed] [Cross Ref]
24. Lee A, O'Rourke J, Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology. 1997;112:1386–1397. doi: 10.1016/S0016-5085(97)70155-0. [PubMed] [Cross Ref]
25. Velin D, Bachmann D, Bouzourene H, Michetti P. Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model. Gastroenterology. 2005;129:142–155. doi: 10.1053/j.gastro.2005.04.010. [PubMed] [Cross Ref]
26. Hayat M, Arora DS, Dixon MF, Clark B, O'Mahony S. Effects of Helicobacter pylori eradication on the natural history of lymphocytic gastritis. Gut. 1999;45:495–498. doi: 10.1136/gut.45.4.495. [PMC free article] [PubMed] [Cross Ref]
27. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–1181. doi: 10.1097/00000478-199610000-00001. [PubMed] [Cross Ref]
28. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, Brooks EG, Graham DY, Reyes VE, Ernst PB. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology. 1998;114:482–492. doi: 10.1016/S0016-5085(98)70531-1. [PubMed] [Cross Ref]
29. Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol. 2000;165:1022–1029. [PubMed]
30. Sommer F, Faller G, Rollinghoff M, Kirchner T, Mak TW, Lohoff M. Lack of gastritis and of an adaptive immune response in interferon regulatory factor-1-deficient mice infected with Helicobacter pylori. Eur J Immunol. 2001;31:396–402. doi: 10.1002/1521-4141(200102)31:2<396::AID-IMMU396>3.0.CO;2-Y. [PubMed] [Cross Ref]
31. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev. 2007;6:169–175. doi: 10.1016/j.autrev.2006.10.002. [PubMed] [Cross Ref]
32. McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 2006;27:17–23. doi: 10.1016/ [PubMed] [Cross Ref]
33. Brandtzaeg P, Bjerke K, Kett K, Kvale D, Rognum TO, Scott H, Sollid LM, Valnes K. Production and secretion of immunoglobulins in the gastrointestinal tract. Ann Allergy. 1987;59:21–39. [PubMed]
34. Hopken UE, Achtman AH, Kruger K, Lipp M. Distinct and overlapping roles of CXCR5 and CCR7 in B-1 cell homing and early immunity against bacterial pathogens. J Leukoc Biol. 2004;76:709–718. doi: 10.1189/jlb.1203643. [PubMed] [Cross Ref]
35. Mueller A, O'Rourke J, Chu P, Chu A, Dixon MF, Bouley DM, Lee A, Falkow S. The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Am J Pathol. 2005;167:797–812. [PubMed]
36. Maglione PJ, Xu J, Chan J. B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis. J Immunol. 2007;178:7222–7234. [PubMed]
37. Sawai N, Kita M, Kodama T, Tanahashi T, Yamaoka Y, Tagawa Y, Iwakura Y, Imanishi J. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun. 1999;67:279–285. [PMC free article] [PubMed]
38. Sayi A, Kohler E, Hitzler I, Arnold I, Schwendener R, Rehrauer H, Muller A. The CD4+ T cell-mediated IFN-gamma response to Helicobacter infection is essential for clearance and determines gastric cancer risk. J Immunol. 2009;182:7085–7101. doi: 10.4049/jimmunol.0803293. [PubMed] [Cross Ref]
39. Caruso R, Pallone F, Monteleone G. Emerging role of IL-23/IL-17 axis in H. pylori-associated pathology. World J Gastroenterol. 2007;13:5547–5551. [PubMed]
40. Curtis MM, Way SS, Wilson CB. IL-23 promotes the production of IL-17 by antigen-specific CD8 T cells in the absence of IL-12 and type-I interferons. J Immunol. 2009;183:381–387. doi: 10.4049/jimmunol.0900939. [PMC free article] [PubMed] [Cross Ref]
41. Dubin PJ, Kolls JK. Th17 cytokines and mucosal immunity. Immunol Rev. 2008;226:160–171. doi: 10.1111/j.1600-065X.2008.00703.x. [PubMed] [Cross Ref]
42. Shiomi S, Toriie A, Imamura S, Konishi H, Mitsufuji S, Iwakura Y, Yamaoka Y, Ota H, Yamamoto T, Imanishi J, Kita M. IL-17 is involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Helicobacter. 2008;13:518–524. doi: 10.1111/j.1523-5378.2008.00629.x. [PMC free article] [PubMed] [Cross Ref]
43. Otani K, Watanabe T, Tanigawa T, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, Arakawa T. Anti-inflammatory effects of IL-17A on Helicobacter pylori-induced gastritis. Biochem Biophys Res Commun. 2009;382:252–258. doi: 10.1016/j.bbrc.2009.02.107. [PubMed] [Cross Ref]
44. Algood HM, Allen SS, Washington MK, Peek RM, Jr, Miller GG, Cover TL. Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection. J Immunol. 2009;183:5837–5846. doi: 10.4049/jimmunol.0901206. [PMC free article] [PubMed] [Cross Ref]
45. Junt T, Fink K, Forster R, Senn B, Lipp M, Muramatsu M, Zinkernagel RM, Ludewig B, Hengartner H. CXCR5-dependent seeding of follicular niches by B and Th cells augments antiviral B cell responses. J Immunol. 2005;175:7109–7116. [PubMed]
46. Nagai S, Mimuro H, Yamada T, Baba Y, Moro K, Nochi T, Kiyono H, Suzuki T, Sasakawa C, Koyasu S. Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis. Proc Natl Acad Sci USA. 2007;104:8971–8976. doi: 10.1073/pnas.0609014104. [PubMed] [Cross Ref]
47. Kiriya K, Watanabe N, Nishio A, Okazaki K, Kido M, Saga K, Tanaka J, Akamatsu T, Ohashi S, Asada M, Fukui T, Chiba T. Essential role of Peyer's patches in the development of Helicobacter-induced gastritis. Int Immunol. 2007;19:435–446. doi: 10.1093/intimm/dxm008. [PubMed] [Cross Ref]

Articles from Springer Open Choice are provided here courtesy of Springer